Takeda to Acquire Adaptate Biotherapeutics to D...
07/01/2022 · − Acquisition Adds Adaptate's Novel Antibodybased γδ Tcell Engager Platform to Takeda's Immunooncology Portfolio Built Around the Innate Immune System − Successful Multiyear RD Partnership Results in Takeda's Third Oncology "BuildtoBuy" Acquisition Announced in Less Than a Year OSAKA, Japa...